ResearchJun 13, 20260 views

Developing WNT-derived bone anabolic peptides for skeletal aging and fracture by reconstructing thumb and index domains of WNT7B.

WNT7B-derived peptides just got a major spotlight. Researchers in China and the US have reconstructed the “thumb and index” domains of WNT7B, creating a novel bone anabolic peptide—WNT7BRTID—that could shake up skeletal aging and fracture repair research.

P

Nat Biomed Eng

by Yu F, Li F, Yu P et al.

Developing WNT-derived bone anabolic peptides for skeletal aging and fracture by reconstructing thumb and index domains of WNT7B. Yu F(#)(1)(2), Li F(#)(3)(4), Yu P(#)(3), Zhou B(5), Wang CY(6)(7), Ye L(8)(9). Author information: (1)State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China. fanyuan_yu@outlook.com. (2)Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China. fanyuan_yu@outlook.com. (3)State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China. (4)Department of Pediatric Dentistry, West China Hospital of Stomatology, Sichuan University, Chengdu, China. (5)New Cornerstone Science Laboratory, Key Laboratory of Multi-Cell Systems, Shanghai Institute of Biochemistry and Cell Biology, Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China. (6)Laboratory of Molecular Signaling, Jonsson Comprehensive Cancer Center and Division of Oral and Systemic Health Sciences, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA. cunywang@ucla.edu. (7)Beijing Advanced Center of Cellular Homeostasis and Aging-Related Diseases, Institute of Advanced Clinical Medicine, Peking University, Beijing, China. cunywang@ucla.edu. (8)State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China. yeling@scu.edu.cn. (9)Department of Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China. yeling@scu.edu.cn. (#)Contributed equally WNT proteins have been recognized as key regulators of skeletal health. However, developing WNT-associated bone anabolic agents is clinically challenging and expensive. Here we identify the reconstructed thumb and index domains of WNT7B (WNT7BRTID) as a WNT-derived bone anabolic peptide via Alphafold-empowered sequence prediction and in silico docking screening. In aged mice and pigs models of osteoporosis, WNT7BRTID peptides demonstrate therapeutic potential by improving the osteogenic potential of mesenchymal stromal/stem cells (MSCs) and enhancing bone regeneration. Using single-cell sequencing, transgenic lineage tracking and biochemical approaches, we show that WNT7BRTID harnesses the function and osteogenic lineage generation of intrinsic tissue-residual MSCs without needing MSC transplantation to repair a critical-sized defect effectively. Mechanistically, WNT7BRTID activates non-canonical Ca2+-NFAT signalling through RECK/GPR124 to drive its bone anabolic effects, independent of canonical Wnt/β-catenin signalling known for its oncogenic effects. Our results suggest that WNT7BRTID could work as bone anabolic agent for alleviating bone loss in aging and for fracture repair by promoting MSC function via Ca2+-NFAT signalling. © 2026. The Author(s). Conflict of interest statement: Competing interests: F.Y., F.L., P.Y. and L.Y. are inventors of a pending patent application related to the work described. The other authors declare no competing interests.

Here’s the punchline: WNT proteins have always been the go-to for skeletal health, but turning them into practical bone-building agents has been a headache. The team sidestepped the usual complexity by using Alphafold sequence prediction and in silico docking, mapping out a streamlined domain that packs the anabolic punch without the full WNT protein baggage.

Key findings from the animal models:

WNT7BRTID peptides boosted the bone-forming (osteogenic) power of mesenchymal stromal/stem cells (MSCs) in both old mice and pigs.

Bone regeneration improved without the need to transplant extra stem cells. The peptide made the animal’s own MSCs work harder.

They nailed down the mechanism: WNT7BRTID activates the Ca2+-NFAT pathway via RECK/GPR124, skipping the Wnt/β-catenin signaling that’s often linked to unwanted cell growth.

This isn’t just another incremental peptide tweak. It’s a targeted approach that shows peptides can be designed for specific, high-value biological effects. No need for cell transplants, no baggage from canonical WNT pathways, and results in two different animal models.

For researchers tracking new ways to address osteoporosis or tough-to-heal fractures, this is a signpost: WNT-derived peptides are a live wire. If you’re mapping out your next study or looking for more on the science behind bone-active peptides, check the peptide research index.

Peptide engineering isn’t slowing down, and the WNT7BRTID story just raised the bar.

For Research Use Only

All content published on Pushing Peptides is intended for educational and informational purposes only. The information provided is not intended as medical advice, diagnosis, or treatment. Peptides discussed in this article are research compounds and are not approved for human therapeutic use by the FDA or any other regulatory agency. All studies referenced involve animal models or in vitro research unless otherwise stated. Consult a qualified healthcare professional before making any decisions related to your health. Pushing Peptides does not sell peptides — we are a vendor directory and educational resource.